Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales
Aztreonam-avibactam demonstrated potent activity against a large collection of Enterobacterales isolated from patients with BSI in US hospitals, including CRE, MBL producers, and isolates resistant to recently approved β-lactamase inhibitor combinations.
Authors
- John H. Kimbrough (ORCID: https://orcid.org/0000-0002-0457-1543)
- Rodrigo E. Mendes (ORCID: https://orcid.org/0000-0002-8648-1137)
- Mariana Castanheira (ORCID: https://orcid.org/0000-0003-0126-1782)
- Hélio S. Sader (ORCID: https://orcid.org/0000-0001-7022-6644)
Institutions
- JMI Laboratories (US)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1186/s12879-024-10133-5
- Citations
- 9
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 1.53
Funders
- AbbVie